{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "07",
                "@timestamp": "2022-09-07T03:26:22.000022-04:00",
                "@year": "2022",
                "@month": "09"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "12"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-id": "CU-GR 60093303",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Siriraj Hospital",
                    "xocs:funding-agency": "Faculty of Medicine Siriraj Hospital, Mahidol University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100013238",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-09-06T00:30:41.291Z",
            "xocs:funding-text": [
                {"$": "This research was funded by Chulalongkorn University (CU-GR 60093303 to S.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."},
                {"$": "The authors thank all the kidney transplant recipients participating in this study. We would also like to thank the staff of Siriraj Hospital and Chulalongkorn University for their assistance."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pharmacy Practice"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113044315"
                            },
                            "@affiliation-instance-id": "2018720569-3540c9627ef5a4b9166d43fa8c7a68aa",
                            "ce:source-text": "Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand",
                            "@dptid": "113044315"
                        },
                        "author": [
                            {
                                "ce:given-name": "Teerada",
                                "preferred-name": {
                                    "ce:given-name": "Teerada",
                                    "ce:initials": "T.",
                                    "ce:surname": "Susomboon",
                                    "ce:indexed-name": "Susomboon T."
                                },
                                "@author-instance-id": "2018720569-6521dbc7c069ba3adce19a06ed077175",
                                "@seq": "1",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Susomboon",
                                "@auid": "57189869689",
                                "ce:indexed-name": "Susomboon T."
                            },
                            {
                                "ce:given-name": "Yotsaya",
                                "preferred-name": {
                                    "ce:given-name": "Yotsaya",
                                    "ce:initials": "Y.",
                                    "ce:surname": "Kunlamas",
                                    "ce:indexed-name": "Kunlamas Y."
                                },
                                "@author-instance-id": "2018720569-b3cb02f1a8b220a5c7bfe1a79f6baf91",
                                "@seq": "2",
                                "ce:initials": "Y.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Kunlamas",
                                "@auid": "57206728116",
                                "ce:indexed-name": "Kunlamas Y."
                            },
                            {
                                "ce:given-name": "Somratai",
                                "preferred-name": {
                                    "ce:given-name": "Somratai",
                                    "ce:initials": "S.",
                                    "ce:surname": "Vadcharavivad",
                                    "ce:indexed-name": "Vadcharavivad S."
                                },
                                "@author-instance-id": "2018720569-18943d40b29ad8393254f41def1d31a3",
                                "@seq": "3",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Vadcharavivad",
                                "@auid": "6506736554",
                                "ce:indexed-name": "Vadcharavivad S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10700",
                            "@afid": "60199575",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine Siriraj Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199575",
                                    "@dptid": "125758157"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2018720569-97df43ab920452063b573cee4527f545",
                            "ce:source-text": "Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand",
                            "@dptid": "125758157"
                        },
                        "author": [{
                            "ce:given-name": "Attapong",
                            "preferred-name": {
                                "ce:given-name": "Attapong",
                                "ce:initials": "A.",
                                "ce:surname": "Vongwiwatana",
                                "ce:indexed-name": "Vongwiwatana A."
                            },
                            "@author-instance-id": "2018720569-36728baff54e09c7b18595a12905c297",
                            "@seq": "4",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Vongwiwatana",
                            "@auid": "8777726000",
                            "ce:indexed-name": "Vongwiwatana A."
                        }]
                    }
                ],
                "citation-title": "The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial",
                "abstracts": "Â© 2022, The Author(s).The objective of this study was to assess the effect of the very low dosage of diltiazem on tacrolimus exposure during the first week post-kidney transplantation, among cytochrome P450 (CYP) 3A5 expressers who did not receive diltiazem (EXplb), CYP3A5 expressers who received the very low dose diltiazem (EXdtz), CYP3A5 nonexpressers who did not receive diltiazem (NEplb), and CYP3A5 nonexpressers who received the very low dose diltiazem (NEdtz). Forty kidney recipients who receive tacrolimus-based immunosuppressive regimen were randomly assigned, with stratification on the CYP3A5 genotypes, to receive either diltiazem 30 mg every 12 h or a matched placebo. The observed median dose-adjusted area under the 12-h curve of tacrolimus concentration (AUC/D) at day 7 post-transplantation was lowest in the EXplb group followed by EXdtz, NEplb, and NEdtz at 34.9, 43.6, 49.4, and 71.1 ng*h/mL per mg, respectively. A Kruskal\u2013Wallis test showed a significant difference in the mean ranks of AUC/D among groups. Significant differences between EXplb and NEplb, and between EXplb and NEdtz were demonstrated, whereas no sufficient evidence of significant differences was detected between the other pairs. In conclusion, coadministration of diltiazem 30 mg twice daily may be advantageous for increasing tacrolimus exposure early after kidney transplantation among CYP3A5 expressers.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Pharmacy Practice"},
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Somratai",
                        "ce:initials": "S.",
                        "ce:surname": "Vadcharavivad",
                        "ce:indexed-name": "Vadcharavivad S."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "www.nature.com/srep/index.html",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Scientific Reports",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {
                        "@volume": "12",
                        "@issue": "1"
                    }},
                    "@type": "j",
                    "sourcetitle": "Scientific Reports",
                    "publicationdate": {
                        "month": "12",
                        "year": "2022",
                        "date-text": "December 2022",
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "Sci. Rep.",
                    "@country": "gbr",
                    "issn": {
                        "$": "20452322",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Nature Research"},
                    "article-number": "14247",
                    "@srcid": "21100200805"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "ASJC",
                            "classification": "1000"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MULT"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "329322-82-9",
                                    "chemical-name": "cytochrome P450 3A"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "33286-22-5"},
                                        {"$": "42399-41-7"}
                                    ],
                                    "chemical-name": "diltiazem"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "104987-11-3"},
                                        {"$": "109581-93-3"}
                                    ],
                                    "chemical-name": "tacrolimus"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Cytochrome P-450 CYP3A"},
                                {"chemical-name": "Diltiazem"},
                                {"chemical-name": "Immunosuppressive Agents"},
                                {"chemical-name": "Tacrolimus"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The authors thank all the kidney transplant recipients participating in this study. We would also like to thank the staff of Siriraj Hospital and Chulalongkorn University for their assistance.",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-id": "CU-GR 60093303",
                            "grant-acronym": "CU",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Chulalongkorn University"
                            },
                            "grant-agency-id": "501100002873"
                        },
                        {
                            "grant-id": "CU-GR 60093303",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Department of Electrical Engineering, Chulalongkorn University"
                            },
                            "grant-agency-id": "501100006540"
                        },
                        {
                            "grant-id": "CU-GR 60093303",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Department of Microbiology, Faculty of Science, Chulalongkorn University"
                            },
                            "grant-agency-id": "501100020969"
                        },
                        {
                            "grant-id": "CU-GR 60093303",
                            "grant-acronym": "AHS",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Faculty of Allied Health Sciences, Chulalongkorn University"
                            },
                            "grant-agency-id": "501100018715"
                        },
                        {
                            "grant-id": "CU-GR 60093303",
                            "grant-acronym": "CU-VET",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Faculty of Veterinary Science, Chulalongkorn University"
                            },
                            "grant-agency-id": "501100020619"
                        },
                        {
                            "grant-id": "CU-GR 60093303",
                            "grant-acronym": "MDCU",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Faculty of Medicine, Chulalongkorn University"
                            },
                            "grant-agency-id": "501100004776"
                        },
                        {
                            "grant-id": "CU-GR 60093303",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Faculty of Science, Chulalongkorn University"
                            },
                            "grant-agency-id": "501100015239"
                        },
                        {
                            "grant-id": "CU-GR 60093303",
                            "grant-acronym": "PPC",
                            "grant-agency": {
                                "@iso-code": "tha",
                                "$": "Petroleum and Petrochemical College, Chulalongkorn University"
                            },
                            "grant-agency-id": "501100016154"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNSOC"},
                    {"$": "Scopusbase"},
                    {"$": "MEDL"}
                ],
                "history": {"date-created": {
                    "@day": "05",
                    "@timestamp": "BST 14:36:46",
                    "@year": "2022",
                    "@month": "09"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2018720569",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "942606121",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "2022374346",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20222603801",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20223037479",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2022103793",
                            "@idtype": "SNSOC"
                        },
                        {
                            "$": "20229018980021",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85136928082",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85136928082",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "638800005",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "35989346",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "298817299",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1038/s41598-022-18552-7"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "48",
                "reference": [
                    {
                        "ref-fulltext": "Wallemacq, P. et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: Report of the European consensus conference. Ther. Drug Monit. 31, 139\u2013152 (2009). DOI: 10.1097/FTD.0b013e318198d092",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Opportunities to optimize tacrolimus therapy in solid organ transplantation: Report of the European consensus conference"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/FTD.0b013e318198d092",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "65349115890",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "139",
                                    "@last": "152"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD1MXjsFWqsb0%3D, PID: 19177031",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Wallemacq",
                                    "ce:indexed-name": "Wallemacq P."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther. Drug Monit."
                        },
                        "ce:source-text": "Wallemacq, P. et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: Report of the European consensus conference. Ther. Drug Monit. 31, 139\u2013152 (2009). DOI: 10.1097/FTD.0b013e318198d092"
                    },
                    {
                        "ref-fulltext": "Ekberg, H. et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N. Engl. J. Med. 357, 2562\u20132575 (2007). DOI: 10.1056/NEJMoa067411",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Reduced exposure to calcineurin inhibitors in renal transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa067411",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "37349034394",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "357"},
                                "pagerange": {
                                    "@first": "2562",
                                    "@last": "2575"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD2sXhsVKht7nO, PID: 18094377",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Ekberg",
                                    "ce:indexed-name": "Ekberg H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Ekberg, H. et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N. Engl. J. Med. 357, 2562\u20132575 (2007). DOI: 10.1056/NEJMoa067411"
                    },
                    {
                        "ref-fulltext": "Dugast, E. et al. Failure of calcineurin inhibitor (tacrolimus) weaning randomized trial in long-term stable kidney transplant recipients. Am. J. Transplant. 16, 3255\u20133261 (2016). DOI: 10.1111/ajt.13946",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Failure of calcineurin inhibitor (tacrolimus) weaning randomized trial in long-term stable kidney transplant recipients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/ajt.13946",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84989216656",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "3255",
                                    "@last": "3261"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC28XhslCktLnE, PID: 27367750",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Dugast",
                                    "ce:indexed-name": "Dugast E."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am. J. Transplant."
                        },
                        "ce:source-text": "Dugast, E. et al. Failure of calcineurin inhibitor (tacrolimus) weaning randomized trial in long-term stable kidney transplant recipients. Am. J. Transplant. 16, 3255\u20133261 (2016). DOI: 10.1111/ajt.13946"
                    },
                    {
                        "ref-fulltext": "Hricik, D. E. et al. Adverse outcomes of tacrolimus withdrawal in immune\u2013quiescent kidney transplant recipients. J. Am. Soc. Nephrol. 26, 3114\u20133122 (2015). DOI: 10.1681/ASN.2014121234",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Adverse outcomes of tacrolimus withdrawal in immune\u2013quiescent kidney transplant recipients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1681/ASN.2014121234",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84944092747",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "3114",
                                    "@last": "3122"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC28XhtFOntLnJ, PID: 25925687",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Hricik",
                                    "ce:indexed-name": "Hricik D.E."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Am. Soc. Nephrol."
                        },
                        "ce:source-text": "Hricik, D. E. et al. Adverse outcomes of tacrolimus withdrawal in immune\u2013quiescent kidney transplant recipients. J. Am. Soc. Nephrol. 26, 3114\u20133122 (2015). DOI: 10.1681/ASN.2014121234"
                    },
                    {
                        "ref-fulltext": "Oberbauer, R. et al. Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. Transplant. Rev. 34, 1\u20139 (2020). DOI: 10.1016/j.trre.2020.100531",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.trre.2020.100531",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85136940590",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "9"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Oberbauer",
                                    "ce:indexed-name": "Oberbauer R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Transplant. Rev."
                        },
                        "ce:source-text": "Oberbauer, R. et al. Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. Transplant. Rev. 34, 1\u20139 (2020). DOI: 10.1016/j.trre.2020.100531"
                    },
                    {
                        "ref-fulltext": "Zwart, T. C. et al. Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation. Drug Discov. Today 26, 2527\u20132546 (2021). DOI: 10.1016/j.drudis.2021.06.001",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.drudis.2021.06.001",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85108580292",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "2527",
                                    "@last": "2546"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BB3MXhvFGjsbjK, PID: 34119665",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Zwart",
                                    "ce:indexed-name": "Zwart T.C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Discov. Today"
                        },
                        "ce:source-text": "Zwart, T. C. et al. Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation. Drug Discov. Today 26, 2527\u20132546 (2021). DOI: 10.1016/j.drudis.2021.06.001"
                    },
                    {
                        "ref-fulltext": "Andrews, L. M. et al. Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients. Expert Opin. Drug Metab. Toxicol. 13, 1225\u20131236 (2017). DOI: 10.1080/17425255.2017.1395413",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/17425255.2017.1395413",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85036568358",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "1225",
                                    "@last": "1236"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC2sXhslCmt7bK, PID: 29084469",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Andrews",
                                    "ce:indexed-name": "Andrews L.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Expert Opin. Drug Metab. Toxicol."
                        },
                        "ce:source-text": "Andrews, L. M. et al. Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients. Expert Opin. Drug Metab. Toxicol. 13, 1225\u20131236 (2017). DOI: 10.1080/17425255.2017.1395413"
                    },
                    {
                        "ref-fulltext": "Staatz, C. E., Goodman, L. K. & Tett, S. E. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clin. Pharmacokinet. 49, 141\u2013175 (2010). DOI: 10.2165/11317350-000000000-00000",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2165/11317350-000000000-00000",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77249125964",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "49"},
                                "pagerange": {
                                    "@first": "141",
                                    "@last": "175"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC3cXkvVSktLo%3D, PID: 20170205",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Staatz",
                                    "ce:indexed-name": "Staatz C.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Goodman",
                                    "ce:indexed-name": "Goodman L.K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Tett",
                                    "ce:indexed-name": "Tett S.E."
                                }
                            ]},
                            "ref-sourcetitle": "Clin. Pharmacokinet."
                        },
                        "ce:source-text": "Staatz, C. E., Goodman, L. K. & Tett, S. E. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clin. Pharmacokinet. 49, 141\u2013175 (2010). DOI: 10.2165/11317350-000000000-00000"
                    },
                    {
                        "ref-fulltext": "Phupradit, A. et al. Impact of POR and CYP3A5 polymorphisms on trough concentration to dose ratio of tacrolimus in the early post-operative period following kidney transplantation. Ther. Drug Monit. 40, 549\u2013557 (2018). DOI: 10.1097/FTD.0000000000000542",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Impact of POR and CYP3A5 polymorphisms on trough concentration to dose ratio of tacrolimus in the early post-operative period following kidney transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/FTD.0000000000000542",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85064121799",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {
                                    "@first": "549",
                                    "@last": "557"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC1cXhslSgu7zL, PID: 29878980",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Phupradit",
                                    "ce:indexed-name": "Phupradit A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther. Drug Monit."
                        },
                        "ce:source-text": "Phupradit, A. et al. Impact of POR and CYP3A5 polymorphisms on trough concentration to dose ratio of tacrolimus in the early post-operative period following kidney transplantation. Ther. Drug Monit. 40, 549\u2013557 (2018). DOI: 10.1097/FTD.0000000000000542"
                    },
                    {
                        "ref-fulltext": "Hesselink, D. A., Bouamar, R., Elens, L., van Schaik, R. H. N. & van Gelder, T. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. Clin. Pharmacokinet. 53, 123\u2013139 (2014). DOI: 10.1007/s40262-013-0120-3",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s40262-013-0120-3",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84893233177",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "53"},
                                "pagerange": {
                                    "@first": "123",
                                    "@last": "139"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC2cXhsFChsr8%3D, PID: 24249597",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Hesselink",
                                    "ce:indexed-name": "Hesselink D.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Bouamar",
                                    "ce:indexed-name": "Bouamar R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Elens",
                                    "ce:indexed-name": "Elens L."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.H.N.",
                                    "@_fa": "true",
                                    "ce:surname": "van Schaik",
                                    "ce:indexed-name": "van Schaik R.H.N."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "van Gelder",
                                    "ce:indexed-name": "van Gelder T."
                                }
                            ]},
                            "ref-sourcetitle": "Clin. Pharmacokinet."
                        },
                        "ce:source-text": "Hesselink, D. A., Bouamar, R., Elens, L., van Schaik, R. H. N. & van Gelder, T. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. Clin. Pharmacokinet. 53, 123\u2013139 (2014). DOI: 10.1007/s40262-013-0120-3"
                    },
                    {
                        "ref-fulltext": "Undre, N. A. et al. Low systemic exposure to tacrolimus correlates with acute rejection. Transplant. Proc. 31, 296\u2013298 (1999). DOI: 10.1016/S0041-1345(98)01633-9",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1999"},
                            "ref-title": {"ref-titletext": "Low systemic exposure to tacrolimus correlates with acute rejection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0041-1345(98)01633-9",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0032986187",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "296",
                                    "@last": "298"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DyaK1MXhvVGmurg%3D, PID: 10083114",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "N.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Undre",
                                    "ce:indexed-name": "Undre N.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Transplant. Proc."
                        },
                        "ce:source-text": "Undre, N. A. et al. Low systemic exposure to tacrolimus correlates with acute rejection. Transplant. Proc. 31, 296\u2013298 (1999). DOI: 10.1016/S0041-1345(98)01633-9"
                    },
                    {
                        "ref-fulltext": "Borobia, A. M. et al. Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection. Ther. Drug Monit. 31, 436\u2013442 (2009). DOI: 10.1097/FTD.0b013e3181a8f02a",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/FTD.0b013e3181a8f02a",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "68449089526",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "436",
                                    "@last": "442"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD1MXptVeks7g%3D, PID: 19494792",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Borobia",
                                    "ce:indexed-name": "Borobia A.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther. Drug Monit."
                        },
                        "ce:source-text": "Borobia, A. M. et al. Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection. Ther. Drug Monit. 31, 436\u2013442 (2009). DOI: 10.1097/FTD.0b013e3181a8f02a"
                    },
                    {
                        "ref-fulltext": "O\u2019Seaghdha, C. M. et al. Higher tacrolimus trough levels on days 2\u20135 post-renal transplant are associated with reduced rates of acute rejection. Clin. Transplant. 23, 462\u2013468 (2009). DOI: 10.1111/j.1399-0012.2009.01021.x",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Higher tacrolimus trough levels on days 2\u20135 post-renal transplant are associated with reduced rates of acute rejection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1399-0012.2009.01021.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "68349139533",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "462",
                                    "@last": "468"
                                }
                            },
                            "ref-text": "PID: 19681975",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.M.",
                                    "@_fa": "true",
                                    "ce:surname": "O\u2019Seaghdha",
                                    "ce:indexed-name": "O'Seaghdha C.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Transplant."
                        },
                        "ce:source-text": "O\u2019Seaghdha, C. M. et al. Higher tacrolimus trough levels on days 2\u20135 post-renal transplant are associated with reduced rates of acute rejection. Clin. Transplant. 23, 462\u2013468 (2009). DOI: 10.1111/j.1399-0012.2009.01021.x"
                    },
                    {
                        "ref-fulltext": "Richards, K. R. et al. Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. Transplantation 97, 986\u2013991 (2014). DOI: 10.1097/TP.0000000000000149",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/TP.0000000000000149",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84901268183",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "97"},
                                "pagerange": {
                                    "@first": "986",
                                    "@last": "991"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC2cXosVOrsro%3D, PID: 24784360",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Richards",
                                    "ce:indexed-name": "Richards K.R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Transplantation"
                        },
                        "ce:source-text": "Richards, K. R. et al. Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. Transplantation 97, 986\u2013991 (2014). DOI: 10.1097/TP.0000000000000149"
                    },
                    {
                        "ref-fulltext": "MacPhee, I. A. et al. The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. Am. J. Transplant. 4, 914\u2013919 (2004). DOI: 10.1111/j.1600-6143.2004.00435.x",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1600-6143.2004.00435.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "2942588886",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "914",
                                    "@last": "919"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD2cXls1Sgurc%3D, PID: 15147425",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "I.A.",
                                    "@_fa": "true",
                                    "ce:surname": "MacPhee",
                                    "ce:indexed-name": "MacPhee I.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am. J. Transplant."
                        },
                        "ce:source-text": "MacPhee, I. A. et al. The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. Am. J. Transplant. 4, 914\u2013919 (2004). DOI: 10.1111/j.1600-6143.2004.00435.x"
                    },
                    {
                        "ref-fulltext": "Jones, D. R. et al. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation. J. Pharmacol. Exp. Ther. 290, 1116\u20131125 (1999).",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1999"},
                            "ref-title": {"ref-titletext": "Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0032773854",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "290"},
                                "pagerange": {
                                    "@first": "1116",
                                    "@last": "1125"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DyaK1MXlsVOqsb8%3D, PID: 10454485",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Jones",
                                    "ce:indexed-name": "Jones D.R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Pharmacol. Exp. Ther."
                        },
                        "ce:source-text": "Jones, D. R. et al. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation. J. Pharmacol. Exp. Ther. 290, 1116\u20131125 (1999)."
                    },
                    {
                        "ref-fulltext": "Cornwell, M. M., Pastan, I. & Gottesman, M. M. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J. Biol. Chem. 262, 2166\u20132170 (1987). DOI: 10.1016/S0021-9258(18)61633-3",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1987"},
                            "ref-title": {"ref-titletext": "Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0021-9258(18)61633-3",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0023234519",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "262"},
                                "pagerange": {
                                    "@first": "2166",
                                    "@last": "2170"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DyaL2sXhsV2jtb8%3D, PID: 2434476",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Cornwell",
                                    "ce:indexed-name": "Cornwell M.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Pastan",
                                    "ce:indexed-name": "Pastan I."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Gottesman",
                                    "ce:indexed-name": "Gottesman M.M."
                                }
                            ]},
                            "ref-sourcetitle": "J. Biol. Chem."
                        },
                        "ce:source-text": "Cornwell, M. M., Pastan, I. & Gottesman, M. M. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J. Biol. Chem. 262, 2166\u20132170 (1987). DOI: 10.1016/S0021-9258(18)61633-3"
                    },
                    {
                        "ref-fulltext": "Kidney disease: improving global outcomes transplant work group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am. J. Transplant. 9, S1\u2013S155 (2009).",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Kidney disease: Improving global outcomes transplant work group. KDIGO clinical practice guideline for the care of kidney transplant recipients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "75749102266",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "SS1",
                                    "@last": "S155"
                                }
                            },
                            "ref-sourcetitle": "Am. J. Transplant."
                        },
                        "ce:source-text": "Kidney disease: improving global outcomes transplant work group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am. J. Transplant. 9, S1\u2013S155 (2009)."
                    },
                    {
                        "ref-fulltext": "Li, J. L. et al. Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: From retrospective to prospective. Pharmacogenomics J. 11, 300\u2013306 (2011). DOI: 10.1038/tpj.2010.42",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: From retrospective to prospective"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/tpj.2010.42",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79960634582",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "300",
                                    "@last": "306"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC3cXmslWmsbs%3D, PID: 20514078",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li J.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenomics J."
                        },
                        "ce:source-text": "Li, J. L. et al. Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: From retrospective to prospective. Pharmacogenomics J. 11, 300\u2013306 (2011). DOI: 10.1038/tpj.2010.42"
                    },
                    {
                        "ref-fulltext": "ARCHITECT tacrolimus Ref1L77. Abbott Park: Abbott Laboratories Division (2015).",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "ARCHITECT tacrolimus Ref1L77"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85136967127",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-sourcetitle": "Abbott Park: Abbott Laboratories Division"
                        },
                        "ce:source-text": "ARCHITECT tacrolimus Ref1L77. Abbott Park: Abbott Laboratories Division (2015)."
                    },
                    {
                        "ref-fulltext": "Kuehl, P. et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 27, 383\u2013391 (2001). DOI: 10.1038/86882",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/86882",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0035071598",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "383",
                                    "@last": "391"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD3MXjtFShs7k%3D, PID: 11279519",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Kuehl",
                                    "ce:indexed-name": "Kuehl P."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat. Genet."
                        },
                        "ce:source-text": "Kuehl, P. et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 27, 383\u2013391 (2001). DOI: 10.1038/86882"
                    },
                    {
                        "ref-fulltext": "MacPhee, I. A. & Holt, D. W. A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype. Transplantation 85, 163\u2013165 (2008). DOI: 10.1097/TP.0b013e3181609054",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/TP.0b013e3181609054",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "38549140495",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "85"},
                                "pagerange": {
                                    "@first": "163",
                                    "@last": "165"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD1cXptlegsg%3D%3D, PID: 18212618",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "I.A.",
                                    "@_fa": "true",
                                    "ce:surname": "MacPhee",
                                    "ce:indexed-name": "MacPhee I.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Holt",
                                    "ce:indexed-name": "Holt D.W."
                                }
                            ]},
                            "ref-sourcetitle": "Transplantation"
                        },
                        "ce:source-text": "MacPhee, I. A. & Holt, D. W. A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype. Transplantation 85, 163\u2013165 (2008). DOI: 10.1097/TP.0b013e3181609054"
                    },
                    {
                        "ref-fulltext": "Vannaprasaht, S. et al. Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation. Clin. Ther. 35, 1762\u20131769 (2013). DOI: 10.1016/j.clinthera.2013.08.019",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.clinthera.2013.08.019",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84888015274",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {
                                    "@first": "1762",
                                    "@last": "1769"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC3sXhs1SrsLzE, PID: 24120259",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Vannaprasaht",
                                    "ce:indexed-name": "Vannaprasaht S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Ther."
                        },
                        "ce:source-text": "Vannaprasaht, S. et al. Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation. Clin. Ther. 35, 1762\u20131769 (2013). DOI: 10.1016/j.clinthera.2013.08.019"
                    },
                    {
                        "ref-fulltext": "Yaowakulpatana, K. et al. Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation. Eur. J. Clin. Pharmacol. 72, 277\u2013283 (2016). DOI: 10.1007/s00228-015-1990-0",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s00228-015-1990-0",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84958116683",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "72"},
                                "pagerange": {
                                    "@first": "277",
                                    "@last": "283"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC2MXhvFKqs73N, PID: 26635230",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Yaowakulpatana",
                                    "ce:indexed-name": "Yaowakulpatana K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur. J. Clin. Pharmacol."
                        },
                        "ce:source-text": "Yaowakulpatana, K. et al. Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation. Eur. J. Clin. Pharmacol. 72, 277\u2013283 (2016). DOI: 10.1007/s00228-015-1990-0"
                    },
                    {
                        "ref-fulltext": "Chen, L. & Prasad, G. V. R. CYP3A5 polymorphisms in renal transplant recipients: Influence on tacrolimus treatment. Pharmgenomics Pers. Med. 11, 23\u201333 (2018).",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "CYP3A5 polymorphisms in renal transplant recipients: Influence on tacrolimus treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044351850",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "23",
                                    "@last": "33"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC1MXhtVyls7rN, PID: 29563827",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.V.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Prasad",
                                    "ce:indexed-name": "Prasad G.V.R."
                                }
                            ]},
                            "ref-sourcetitle": "Pharmgenomics Pers. Med."
                        },
                        "ce:source-text": "Chen, L. & Prasad, G. V. R. CYP3A5 polymorphisms in renal transplant recipients: Influence on tacrolimus treatment. Pharmgenomics Pers. Med. 11, 23\u201333 (2018)."
                    },
                    {
                        "ref-fulltext": "Park, S. Y., Kang, Y. S., Jeong, M. S., Yoon, H. K. & Han, K. O. Frequencies of CYP3A5 genotypes and haplotypes in a Korean population. J. Clin. Pharm. Ther. 33, 61\u201365 (2008). DOI: 10.1111/j.1365-2710.2008.00879.x",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Frequencies of CYP3A5 genotypes and haplotypes in a Korean population"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1365-2710.2008.00879.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "38349011289",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "61",
                                    "@last": "65"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD1cXjtFCjsbk%3D, PID: 18211618",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park S.Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Kang",
                                    "ce:indexed-name": "Kang Y.S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Jeong",
                                    "ce:indexed-name": "Jeong M.S."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Yoon",
                                    "ce:indexed-name": "Yoon H.K."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "K.O.",
                                    "@_fa": "true",
                                    "ce:surname": "Han",
                                    "ce:indexed-name": "Han K.O."
                                }
                            ]},
                            "ref-sourcetitle": "J. Clin. Pharm. Ther."
                        },
                        "ce:source-text": "Park, S. Y., Kang, Y. S., Jeong, M. S., Yoon, H. K. & Han, K. O. Frequencies of CYP3A5 genotypes and haplotypes in a Korean population. J. Clin. Pharm. Ther. 33, 61\u201365 (2008). DOI: 10.1111/j.1365-2710.2008.00879.x"
                    },
                    {
                        "ref-fulltext": "Supanya, D. et al. Prevalence of CYP3A5 polymorphism in a Thai population. Thai. J. Pharmacol. 31, 95\u201397 (2009).",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Prevalence of CYP3A5 polymorphism in a Thai population"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84883245788",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "95",
                                    "@last": "97"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Supanya",
                                    "ce:indexed-name": "Supanya D."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Thai. J. Pharmacol."
                        },
                        "ce:source-text": "Supanya, D. et al. Prevalence of CYP3A5 polymorphism in a Thai population. Thai. J. Pharmacol. 31, 95\u201397 (2009)."
                    },
                    {
                        "ref-fulltext": "Balram, C., Zhou, Q., Cheung, Y. B. & Lee, E. J. CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations. Eur J Clin Pharmacol. 59, 123\u2013126 (2003). DOI: 10.1007/s00228-003-0594-2",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s00228-003-0594-2",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0038729506",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "59"},
                                "pagerange": {
                                    "@first": "123",
                                    "@last": "126"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD3sXksFGlu7k%3D, PID: 12756511",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Balram",
                                    "ce:indexed-name": "Balram C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Q.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou Q."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheung",
                                    "ce:indexed-name": "Cheung Y.B."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "E.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee E.J."
                                }
                            ]},
                            "ref-sourcetitle": "Eur J Clin Pharmacol."
                        },
                        "ce:source-text": "Balram, C., Zhou, Q., Cheung, Y. B. & Lee, E. J. CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations. Eur J Clin Pharmacol. 59, 123\u2013126 (2003). DOI: 10.1007/s00228-003-0594-2"
                    },
                    {
                        "ref-fulltext": "Zhao, P., Lee, C. A. & Kunze, K. L. Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A. Drug Metab. Dispos. 35, 704\u2013712 (2007). DOI: 10.1124/dmd.106.013847",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1124/dmd.106.013847",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34247356616",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {
                                    "@first": "704",
                                    "@last": "712"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD2sXlsVWmtLY%3D, PID: 17293381",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhao",
                                    "ce:indexed-name": "Zhao P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee C.A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Kunze",
                                    "ce:indexed-name": "Kunze K.L."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Metab. Dispos."
                        },
                        "ce:source-text": "Zhao, P., Lee, C. A. & Kunze, K. L. Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A. Drug Metab. Dispos. 35, 704\u2013712 (2007). DOI: 10.1124/dmd.106.013847"
                    },
                    {
                        "ref-fulltext": "Zhang, X., Quinney, S. K., Gorski, J. C., Jones, D. R. & Hall, S. D. Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite. Drug Metab. Dispos. 37, 1587\u20131597 (2009). DOI: 10.1124/dmd.109.026658",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1124/dmd.109.026658",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "67650812077",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "1587",
                                    "@last": "1597"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD1MXps1ygtrg%3D, PID: 19420129",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang X."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Quinney",
                                    "ce:indexed-name": "Quinney S.K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Gorski",
                                    "ce:indexed-name": "Gorski J.C."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Jones",
                                    "ce:indexed-name": "Jones D.R."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Hall",
                                    "ce:indexed-name": "Hall S.D."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Metab. Dispos."
                        },
                        "ce:source-text": "Zhang, X., Quinney, S. K., Gorski, J. C., Jones, D. R. & Hall, S. D. Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite. Drug Metab. Dispos. 37, 1587\u20131597 (2009). DOI: 10.1124/dmd.109.026658"
                    },
                    {
                        "ref-fulltext": "Sutton, D., Butler, A. M., Nadin, L. & Murray, M. Role of CYP3A4 in human hepatic diltiazem N-demethylation:inhibition of CYP3A4 activity by oxidized diltiazem metabolites. J. Pharmacol. Exp. Ther. 282, 294\u2013300 (1997).",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1997"},
                            "ref-title": {"ref-titletext": "Role of CYP3A4 in human hepatic diltiazem N-demethylation:inhibition of CYP3A4 activity by oxidized diltiazem metabolites"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR31",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0030875423",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "282"},
                                "pagerange": {
                                    "@first": "294",
                                    "@last": "300"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DyaK2sXksFyitb0%3D, PID: 9223567",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Sutton",
                                    "ce:indexed-name": "Sutton D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Butler",
                                    "ce:indexed-name": "Butler A.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Nadin",
                                    "ce:indexed-name": "Nadin L."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Murray",
                                    "ce:indexed-name": "Murray M."
                                }
                            ]},
                            "ref-sourcetitle": "J. Pharmacol. Exp. Ther."
                        },
                        "ce:source-text": "Sutton, D., Butler, A. M., Nadin, L. & Murray, M. Role of CYP3A4 in human hepatic diltiazem N-demethylation:inhibition of CYP3A4 activity by oxidized diltiazem metabolites. J. Pharmacol. Exp. Ther. 282, 294\u2013300 (1997)."
                    },
                    {
                        "ref-fulltext": "Mayhew, B. S., Jones, D. R. & Hall, S. D. An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation. Drug Metab. Dispos. 28, 1031\u20131037 (2000).",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR32",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0033831197",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "1031",
                                    "@last": "1037"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD3cXmtFCrtbg%3D, PID: 10950845",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Mayhew",
                                    "ce:indexed-name": "Mayhew B.S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Jones",
                                    "ce:indexed-name": "Jones D.R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Hall",
                                    "ce:indexed-name": "Hall S.D."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Metab. Dispos."
                        },
                        "ce:source-text": "Mayhew, B. S., Jones, D. R. & Hall, S. D. An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation. Drug Metab. Dispos. 28, 1031\u20131037 (2000)."
                    },
                    {
                        "ref-fulltext": "Ma, B., Prueksaritanont, T. & Lin, J. H. Drug interactions with calcium channel blockers: Possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab. Dispos. 28, 125\u2013130 (2000).",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Drug interactions with calcium channel blockers: Possible involvement of metabolite-intermediate complexation with CYP3A"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR33",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0033959578",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "125",
                                    "@last": "130"
                                }
                            },
                            "ref-text": "COI: 1:STN:280:DC%2BD3c7gvVyitw%3D%3D, PID: 10640508",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Ma",
                                    "ce:indexed-name": "Ma B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Prueksaritanont",
                                    "ce:indexed-name": "Prueksaritanont T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Lin",
                                    "ce:indexed-name": "Lin J.H."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Metab. Dispos."
                        },
                        "ce:source-text": "Ma, B., Prueksaritanont, T. & Lin, J. H. Drug interactions with calcium channel blockers: Possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab. Dispos. 28, 125\u2013130 (2000)."
                    },
                    {
                        "ref-fulltext": "Pinto, A. G. et al. Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein. Br. J. Clin. Pharmacol. 59, 440\u2013446 (2005). DOI: 10.1111/j.1365-2125.2005.02343.x",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1365-2125.2005.02343.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR34",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "17144413347",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "59"},
                                "pagerange": {
                                    "@first": "440",
                                    "@last": "446"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD2MXktFals7s%3D, PID: 15801939",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Pinto",
                                    "ce:indexed-name": "Pinto A.G."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br. J. Clin. Pharmacol."
                        },
                        "ce:source-text": "Pinto, A. G. et al. Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein. Br. J. Clin. Pharmacol. 59, 440\u2013446 (2005). DOI: 10.1111/j.1365-2125.2005.02343.x"
                    },
                    {
                        "ref-fulltext": "Pauli-Magnus, C. & Kroetz, D. L. Functional implications of genetic polymorphisms in the multidrug resistance gene. Pharm. Res. 21, 904\u2013913 (2004). DOI: 10.1023/B:PHAM.0000029276.21063.0b",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Functional implications of genetic polymorphisms in the multidrug resistance gene"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1023/B:PHAM.0000029276.21063.0b",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR35",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "3042767682",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "904",
                                    "@last": "913"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD2cXktlykurc%3D, PID: 15212152",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Pauli-Magnus",
                                    "ce:indexed-name": "Pauli-Magnus C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Kroetz",
                                    "ce:indexed-name": "Kroetz D.L."
                                }
                            ]},
                            "ref-sourcetitle": "Pharm. Res."
                        },
                        "ce:source-text": "Pauli-Magnus, C. & Kroetz, D. L. Functional implications of genetic polymorphisms in the multidrug resistance gene. Pharm. Res. 21, 904\u2013913 (2004). DOI: 10.1023/B:PHAM.0000029276.21063.0b"
                    },
                    {
                        "ref-fulltext": "Christians, U. et al. Active drug transport of immuno-suppressants: New insights for pharmacokinetics and pharmacodynamics. Ther. Drug. Monit. 28, 39\u201344 (2006). DOI: 10.1097/01.ftd.0000183385.27394.e7",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Active drug transport of immuno-suppressants: New insights for pharmacokinetics and pharmacodynamics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/01.ftd.0000183385.27394.e7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR36",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33745487508",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "39",
                                    "@last": "44"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD28XkvFKnsA%3D%3D, PID: 16418692",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "U.",
                                    "@_fa": "true",
                                    "ce:surname": "Christians",
                                    "ce:indexed-name": "Christians U."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther. Drug. Monit."
                        },
                        "ce:source-text": "Christians, U. et al. Active drug transport of immuno-suppressants: New insights for pharmacokinetics and pharmacodynamics. Ther. Drug. Monit. 28, 39\u201344 (2006). DOI: 10.1097/01.ftd.0000183385.27394.e7"
                    },
                    {
                        "ref-fulltext": "Jones, T. E. & Morris, R. G. Pharmacokinetic interaction between tacrolimus and diltiazem: Dose\u2013response relationship in kidney and liver transplant recipients. Clin. Pharmacokinet. 41, 381\u2013388 (2002). DOI: 10.2165/00003088-200241050-00005",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic interaction between tacrolimus and diltiazem: Dose\u2013response relationship in kidney and liver transplant recipients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2165/00003088-200241050-00005",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR37",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0036290197",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "381",
                                    "@last": "388"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD38Xlt1Gjur8%3D, PID: 12036394",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Jones",
                                    "ce:indexed-name": "Jones T.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Morris",
                                    "ce:indexed-name": "Morris R.G."
                                }
                            ]},
                            "ref-sourcetitle": "Clin. Pharmacokinet."
                        },
                        "ce:source-text": "Jones, T. E. & Morris, R. G. Pharmacokinetic interaction between tacrolimus and diltiazem: Dose\u2013response relationship in kidney and liver transplant recipients. Clin. Pharmacokinet. 41, 381\u2013388 (2002). DOI: 10.2165/00003088-200241050-00005"
                    },
                    {
                        "ref-fulltext": "Birdwell, K. A. et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Clin. Pharmacol. Ther. 98, 19\u201324 (2015). DOI: 10.1002/cpt.113",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/cpt.113",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR38",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84962207669",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "98"},
                                "pagerange": {
                                    "@first": "19",
                                    "@last": "24"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC2MXhtVOms7fN, PID: 25801146",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Birdwell",
                                    "ce:indexed-name": "Birdwell K.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Pharmacol. Ther."
                        },
                        "ce:source-text": "Birdwell, K. A. et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Clin. Pharmacol. Ther. 98, 19\u201324 (2015). DOI: 10.1002/cpt.113"
                    },
                    {
                        "ref-fulltext": "Kuypers, D. R. J. et al. Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients. Ther. Drug Monit. 32, 394\u2013404 (2010). DOI: 10.1097/FTD.0b013e3181e06818",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/FTD.0b013e3181e06818",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR39",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77955174312",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "32"},
                                "pagerange": {
                                    "@first": "394",
                                    "@last": "404"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC3cXptVyks7k%3D, PID: 20526235",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.R.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Kuypers",
                                    "ce:indexed-name": "Kuypers D.R.J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther. Drug Monit."
                        },
                        "ce:source-text": "Kuypers, D. R. J. et al. Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients. Ther. Drug Monit. 32, 394\u2013404 (2010). DOI: 10.1097/FTD.0b013e3181e06818"
                    },
                    {
                        "ref-fulltext": "Egeland, E. J. et al. High tacrolimus clearance is a risk factor for acute rejection in the early phase after renal transplantation. Transplantation 101, 273\u2013279 (2017). DOI: 10.1097/TP.0000000000001796",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "High tacrolimus clearance is a risk factor for acute rejection in the early phase after renal transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/TP.0000000000001796",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR40",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85026904713",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "101"},
                                "pagerange": {
                                    "@first": "273",
                                    "@last": "279"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BC2sXht1SmsLjJ",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Egeland",
                                    "ce:indexed-name": "Egeland E.J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Transplantation"
                        },
                        "ce:source-text": "Egeland, E. J. et al. High tacrolimus clearance is a risk factor for acute rejection in the early phase after renal transplantation. Transplantation 101, 273\u2013279 (2017). DOI: 10.1097/TP.0000000000001796"
                    },
                    {
                        "ref-fulltext": "ThÃ¶lking, G. et al. The tacrolimus metabolism rate influences renal function after kidney transplantation. PLoS ONE 9, e111128 (2014). DOI: 10.1371/journal.pone.0111128",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "The tacrolimus metabolism rate influences renal function after kidney transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pone.0111128",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR41",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e111128",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "84908577279",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "9"}},
                            "ref-text": "PID: 25340655, COI: 1:CAS:528:DC%2BC2cXhvFSktbzF",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "ThÃ¶lking",
                                    "ce:indexed-name": "Tholking G."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS ONE"
                        },
                        "ce:source-text": "ThÃ¶lking, G. et al. The tacrolimus metabolism rate influences renal function after kidney transplantation. PLoS ONE 9, e111128 (2014). DOI: 10.1371/journal.pone.0111128"
                    },
                    {
                        "ref-fulltext": "Jouve, T. et al. The TOMATO study (tacrolimus metabolization in kidney transplantation): Impact of the concentration\u2013dose ratio on death-censored graft survival. Transplantation 104, 1263\u20131271 (2020). DOI: 10.1097/TP.0000000000002920",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The TOMATO study (tacrolimus metabolization in kidney transplantation): Impact of the concentration\u2013dose ratio on death-censored graft survival"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/TP.0000000000002920",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR42",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085190458",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "104"},
                                "pagerange": {
                                    "@first": "1263",
                                    "@last": "1271"
                                }
                            },
                            "ref-text": "PID: 31415035",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Jouve",
                                    "ce:indexed-name": "Jouve T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Transplantation"
                        },
                        "ce:source-text": "Jouve, T. et al. The TOMATO study (tacrolimus metabolization in kidney transplantation): Impact of the concentration\u2013dose ratio on death-censored graft survival. Transplantation 104, 1263\u20131271 (2020). DOI: 10.1097/TP.0000000000002920"
                    },
                    {
                        "ref-fulltext": "SchÃ¼tte-NÃ¼tgen, K. et al. Fast tac metabolizers at risk\u2014It is time for a C/D ratio calculation. J. Clin. Med. 8, 587 (2019). DOI: 10.3390/jcm8050587",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Fast tac metabolizers at risk\u2014It is time for a C/D ratio calculation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/jcm8050587",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR43",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85114199304",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "587"}
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BB3cXhvF2ru7g%3D",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "SchÃ¼tte-NÃ¼tgen",
                                    "ce:indexed-name": "Schutte-Nutgen K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Med."
                        },
                        "ce:source-text": "SchÃ¼tte-NÃ¼tgen, K. et al. Fast tac metabolizers at risk\u2014It is time for a C/D ratio calculation. J. Clin. Med. 8, 587 (2019). DOI: 10.3390/jcm8050587"
                    },
                    {
                        "ref-fulltext": "Staatz, C. E. & Tett, S. E. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin. Pharmacokinet. 43, 623\u2013653 (2004). DOI: 10.2165/00003088-200443100-00001",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2165/00003088-200443100-00001",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR44",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "3242772986",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "43"},
                                "pagerange": {
                                    "@first": "623",
                                    "@last": "653"
                                }
                            },
                            "ref-text": "COI: 1:CAS:528:DC%2BD2cXmvFansLc%3D, PID: 15244495",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Staatz",
                                    "ce:indexed-name": "Staatz C.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Tett",
                                    "ce:indexed-name": "Tett S.E."
                                }
                            ]},
                            "ref-sourcetitle": "Clin. Pharmacokinet."
                        },
                        "ce:source-text": "Staatz, C. E. & Tett, S. E. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin. Pharmacokinet. 43, 623\u2013653 (2004). DOI: 10.2165/00003088-200443100-00001"
                    },
                    {
                        "ref-fulltext": "Kidney disease: improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int., Suppl. 99, S1\u2013S87 (2021).",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "CR45",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "S1\u2013S87",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85136998283",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "99"}},
                            "ref-sourcetitle": "Kidney Int., Suppl."
                        },
                        "ce:source-text": "Kidney disease: improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int., Suppl. 99, S1\u2013S87 (2021)."
                    },
                    {
                        "ref-fulltext": "Ojo, A. O. Cardiovascular complications after renal transplantation and their prevention. Transplantation 82, 603\u2013611 (2006). DOI: 10.1097/01.tp.0000235527.81917.fe",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Cardiovascular complications after renal transplantation and their prevention"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/01.tp.0000235527.81917.fe",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR46",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33748778507",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "82"},
                                "pagerange": {
                                    "@first": "603",
                                    "@last": "611"
                                }
                            },
                            "ref-text": "PID: 16969281",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.O.",
                                "@_fa": "true",
                                "ce:surname": "Ojo",
                                "ce:indexed-name": "Ojo A.O."
                            }]},
                            "ref-sourcetitle": "Transplantation"
                        },
                        "ce:source-text": "Ojo, A. O. Cardiovascular complications after renal transplantation and their prevention. Transplantation 82, 603\u2013611 (2006). DOI: 10.1097/01.tp.0000235527.81917.fe"
                    },
                    {
                        "ref-fulltext": "Kasiske, B. L. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 72, S5-8 (2001). DOI: 10.1097/00007890-200109271-00003",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Epidemiology of cardiovascular disease after renal transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/00007890-200109271-00003",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR47",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0035959992",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "72"},
                                "pagerange": {
                                    "@first": "S5",
                                    "@last": "S8"
                                }
                            },
                            "ref-text": "COI: 1:STN:280:DC%2BD3MrjvVGmtA%3D%3D, PID: 11585242",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "B.L.",
                                "@_fa": "true",
                                "ce:surname": "Kasiske",
                                "ce:indexed-name": "Kasiske B.L."
                            }]},
                            "ref-sourcetitle": "Transplantation"
                        },
                        "ce:source-text": "Kasiske, B. L. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 72, S5-8 (2001). DOI: 10.1097/00007890-200109271-00003"
                    },
                    {
                        "ref-fulltext": "Tantisattamo, E. et al. Approach and management of hypertension after kidney transplantation. Front. Med. 7, 1\u201325 (2020). DOI: 10.3389/fmed.2020.00229",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Approach and management of hypertension after kidney transplantation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fmed.2020.00229",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "CR48",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85087164568",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "25"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Tantisattamo",
                                    "ce:indexed-name": "Tantisattamo E."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front. Med."
                        },
                        "ce:source-text": "Tantisattamo, E. et al. Approach and management of hypertension after kidney transplantation. Front. Med. 7, 1\u201325 (2020). DOI: 10.3389/fmed.2020.00229"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85136928082",
        "dc:description": "The objective of this study was to assess the effect of the very low dosage of diltiazem on tacrolimus exposure during the first week post-kidney transplantation, among cytochrome P450 (CYP) 3A5 expressers who did not receive diltiazem (EXplb), CYP3A5 expressers who received the very low dose diltiazem (EXdtz), CYP3A5 nonexpressers who did not receive diltiazem (NEplb), and CYP3A5 nonexpressers who received the very low dose diltiazem (NEdtz). Forty kidney recipients who receive tacrolimus-based immunosuppressive regimen were randomly assigned, with stratification on the CYP3A5 genotypes, to receive either diltiazem 30 mg every 12 h or a matched placebo. The observed median dose-adjusted area under the 12-h curve of tacrolimus concentration (AUC/D) at day 7 post-transplantation was lowest in the EXplb group followed by EXdtz, NEplb, and NEdtz at 34.9, 43.6, 49.4, and 71.1 ng*h/mL per mg, respectively. A Kruskal\u2013Wallis test showed a significant difference in the mean ranks of AUC/D among groups. Significant differences between EXplb and NEplb, and between EXplb and NEdtz were demonstrated, whereas no sufficient evidence of significant differences was detected between the other pairs. In conclusion, coadministration of diltiazem 30 mg twice daily may be advantageous for increasing tacrolimus exposure early after kidney transplantation among CYP3A5 expressers.",
        "pubmed-id": "35989346",
        "prism:coverDate": "2022-12-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85136928082",
        "dc:creator": {"author": [{
            "ce:given-name": "Teerada",
            "preferred-name": {
                "ce:given-name": "Teerada",
                "ce:initials": "T.",
                "ce:surname": "Susomboon",
                "ce:indexed-name": "Susomboon T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Susomboon",
            "@auid": "57189869689",
            "author-url": "https://api.elsevier.com/content/author/author_id/57189869689",
            "ce:indexed-name": "Susomboon T."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85136928082"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85136928082&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85136928082&origin=inward"
            }
        ],
        "source-id": "21100200805",
        "citedby-count": "2",
        "prism:volume": "12",
        "subtype": "ar",
        "dc:title": "The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial",
        "openaccess": "1",
        "prism:issn": "20452322",
        "publishercopyright": "Â© 2022, The Author(s).",
        "article-number": "14247",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "Scientific Reports",
        "openaccessFlag": "true",
        "prism:doi": "10.1038/s41598-022-18552-7",
        "dc:identifier": "SCOPUS_ID:85136928082",
        "dc:publisher": "Nature Research"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Cytochrome P-450 CYP3A",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Diltiazem",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Genotype",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Immunosuppressive Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Kidney Transplantation",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Tacrolimus",
            "@weight": "a",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Multidisciplinary",
        "@code": "1000",
        "@abbrev": "MULT"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Teerada",
            "preferred-name": {
                "ce:given-name": "Teerada",
                "ce:initials": "T.",
                "ce:surname": "Susomboon",
                "ce:indexed-name": "Susomboon T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Susomboon",
            "@auid": "57189869689",
            "author-url": "https://api.elsevier.com/content/author/author_id/57189869689",
            "ce:indexed-name": "Susomboon T."
        },
        {
            "ce:given-name": "Yotsaya",
            "preferred-name": {
                "ce:given-name": "Yotsaya",
                "ce:initials": "Y.",
                "ce:surname": "Kunlamas",
                "ce:indexed-name": "Kunlamas Y."
            },
            "@seq": "2",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Kunlamas",
            "@auid": "57206728116",
            "author-url": "https://api.elsevier.com/content/author/author_id/57206728116",
            "ce:indexed-name": "Kunlamas Y."
        },
        {
            "ce:given-name": "Somratai",
            "preferred-name": {
                "ce:given-name": "Somratai",
                "ce:initials": "S.",
                "ce:surname": "Vadcharavivad",
                "ce:indexed-name": "Vadcharavivad S."
            },
            "@seq": "3",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Vadcharavivad",
            "@auid": "6506736554",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506736554",
            "ce:indexed-name": "Vadcharavivad S."
        },
        {
            "ce:given-name": "Attapong",
            "preferred-name": {
                "ce:given-name": "Attapong",
                "ce:initials": "A.",
                "ce:surname": "Vongwiwatana",
                "ce:indexed-name": "Vongwiwatana A."
            },
            "@seq": "4",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199575",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"
            },
            "ce:surname": "Vongwiwatana",
            "@auid": "8777726000",
            "author-url": "https://api.elsevier.com/content/author/author_id/8777726000",
            "ce:indexed-name": "Vongwiwatana A."
        }
    ]}
}}